| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9757 |
| Human Intestinal Absorption | HIA+ | 0.9962 |
| Caco-2 Permeability | Caco2+ | 0.8175 |
| P-glycoprotein Substrate | Substrate | 0.7876 |
| P-glycoprotein Inhibitor | Inhibitor | 0.8277 |
| Inhibitor | 0.6426 |
| Renal Organic Cation Transporter | Inhibitor | 0.7960 |
| Distribution |
| Subcellular localization | Lysosome | 0.8977 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7751 |
| CYP450 2D6 Substrate | Substrate | 0.7534 |
| CYP450 3A4 Substrate | Substrate | 0.5825 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.9479 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9106 |
| CYP450 2D6 Inhibitor | Inhibitor | 0.8834 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8963 |
| CYP450 3A4 Inhibitor | Inhibitor | 0.8009 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.6226 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8110 |
| Inhibitor | 0.8677 |
| AMES Toxicity | Non AMES toxic | 0.7891 |
| Carcinogens | Non-carcinogens | 0.9220 |
| Fish Toxicity | High FHMT | 0.9771 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9866 |
| Honey Bee Toxicity | Low HBT | 0.8564 |
| Biodegradation | Not ready biodegradable | 0.9935 |
| Acute Oral Toxicity | III | 0.5798 |
| Carcinogenicity (Three-class) | Non-required | 0.7360 |